Your session is about to expire
← Back to Search
N/A
knee flexion angle 1 for Anterior Cruciate Ligament Injury (FIRM Trial)
N/A
Waitlist Available
Led By Jaskarndip Chahal, MD
Research Sponsored by University of Toronto Orthopaedic Sports Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 12, and 24 months
Awards & highlights
Summary
The purpose of this study is to conduct a randomized controlled trial to determine if the knee flexion angle (KFA) during anterior cruciate ligament reconstruction (ACLR) graft fixation has an effect on postoperative outcomes. The specific research questions are: what is the effect of the KFA on 1) patient-reported outcomes; 2) postoperative extension loss; 3) antero-posterior (AP) knee stability; 4) rate of re-operation.
Eligible Conditions
- Anterior Cruciate Ligament Injury
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3, 6, 12, and 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 12, and 24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Side to side differences in anterior-posterior (AP) stability
the degree of extension loss in the affected knee (vs. contralateral knee)
Trial Design
2Treatment groups
Experimental Treatment
Group I: knee flexion angle 2Experimental Treatment1 Intervention
30 degrees of knee flexion during ACL graft fixation
Group II: knee flexion angle 1Experimental Treatment1 Intervention
0 degrees of knee flexion during ACL graft fixation
Find a Location
Who is running the clinical trial?
Arthroscopy Association of North AmericaOTHER
3 Previous Clinical Trials
449 Total Patients Enrolled
1 Trials studying Anterior Cruciate Ligament Injury
204 Patients Enrolled for Anterior Cruciate Ligament Injury
University of Toronto Orthopaedic Sports MedicineLead Sponsor
2 Previous Clinical Trials
272 Total Patients Enrolled
Jaskarndip Chahal, MDPrincipal InvestigatorUniversity of Toronto Orthopaedic Sports Medicine
Share this study with friends
Copy Link
Messenger